In conclusion, it is necessary to approach the diagnosis and treatment of cancer as a network that integrates multiple signaling pathways such as PI3K/Akt/c-Myc, the nuclear factor kappa B, and PI3K/AKT/mTOR, and to explore potential drug combinations that could regulate this signaling network. Here, MYC is linked to cancer.